Case Number

Title

Non-Confidential Summary

Issued Patent

Lead Inventor's Website

ALN_EMA.023

The ASC Supramolecular Assembly Complex (ASC SMAC), Compositions for Making and Using the Same

NCS for ALN_EMA.023

Link

BAS_REN.005

Cell Lines which Constitutively Express IGF-1 and IGF-1 R

[US Patent No. 5,262,308]
     

Link

BEN_JEF.003

Compositions And Methods For Modulating The Activity Of G Protein-Kinases

[US Patent No. 6,255,069]
     

Link

BER_ERI.002

An In Vivo And In Vitro Model Of Cutaneous Photoaging

[US Patent No. 5,648,061]
[US Patent No. 6,018,098]
   

Link

BIR_DAV.001

Enhanced Formation Of Extracellular Matrix by Overlaying Cultured Cells With A Volume Exclusion Agent

CHU_MON.001

Fibulin-2 Null Mutant Mice

Link

DAN_REN.005

Methods to Measure Frequency of Integration in the Vicinity of Active Genes

Link

FEI_MAR.001

A Transgenic SCID Mouse Model For Hepatitis B Virus Replication And Associated Liver Disease

[US Patent No. 6,087,556]
     

IAC_LOR.001

A Human Model System For In Vitro Development Of The Dopaminergic Phenotype

NCS for IAC_LOR.001

[US Patent No. 7,195,910]
     

Link

IWA_MAS.001

Reproducible and inducible osteoarthritis animal model

Link

KHI_JAS.001

Humanized Cartilage in Mouse

[US Patent No. 6,448,470]
     

MAH_MYG.001

Anti-Desmoglein 1-B Antibodies

NCS for MAH_MYG.001

Link

MUR_SCO.001

Medium for Storing Blood Platelets

MUR_SCO.002

Glucose Free Primary Anticoagulant for Blood Containing Citrate Ions

[US Patent No. 4,925,665]
     

MUR_SCO.004

Acetate Addition to Platelets Stored in Plasma

[US Patent No. 5,234,808]
[US Patent No. 5,344,752]
[US Patent No. 5,474,891]
 

OSH_MIC.001

Chronic Recurring Migraine Headache Model in Rodents

Link

PAC_MAU.005

Prevention and Treatment of Abnormal Ossification and Mineralization

NCS for PAC_MAU.005

SIR_LIN.001

Fibrillin 1 Gene Comprising Suplication Mutation and Method of and Compositions and Kits for Detecting and Using the Same

[US Patent No. 6,010,694]
     

Link

STR_DAV.001

SV40 Viral Vectors for Targeted Integration Into Cells

[US Patent No. 5,863,794]
     

Link

SYK_YUR.004

Invention of a Novel Serum Free Media for Cultivation of Hybridoma Cells to Achieve Production of Highly Homogenous Monoclonal Antibodies (MAb) in Preparative Scale

Link

TSI_PHI.002

Inhibition of TPL2 to Treat Inflammatory Diseases

[US Patent No. 6,660,906]
     

WIC_ERI.002

Peptide Nucleic Acid Conjugates

[US Patent No. 6,180,767]
     

Link